Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

GlaxoSmithKline

ClinicalTrials.gov Identifier:

NCT01753076

First received: December 17, 2012

Last updated: July 9, 2015

Last verified: May 2015

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2015
Primary Completion Date:	November 2014 (Final data collection date for primary outcome measure)
Certification or Request for Extension to Delay Results Received:	May 28, 2015